Analyst Ratings for Amicus Therapeutics (FOLD) [Buys]
FOLD Rating Summary
FOLD Price Target Summary
- Highest: $20.00 (UBS)
- Lowest: $14.00 (BofA Securities)
- Average: $18.20
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$18.20 (+72.7%)
* Over Last 12-Mos
Rating Score: 6.7 / 10
Percentile Rank: 72%
Avg. $ Target:
$18.20 (+72.7%)
* Over Last 12-Mos
Rating Score: 6.7 / 10
Percentile Rank: 72%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 12/19/2023 | Morgan Stanley | Jeffrey Hung | Upgrade | Overweight (Equalweight) |
20.00 (15.00) |
12.72 (10.54) |
-17.14% | Details |
| 1/14/2022 | Leerink Partners | Joseph Schwartz | Upgrade | Outperform (Market Perform) |
16.00 (12.00) |
10.13 (10.54) |
4.05% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
